197 related articles for article (PubMed ID: 26663076)
1. DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana.
Evans-Roberts KM; Mitchenall LA; Wall MK; Leroux J; Mylne JS; Maxwell A
J Biol Chem; 2016 Feb; 291(7):3136-44. PubMed ID: 26663076
[TBL] [Abstract][Full Text] [Related]
2. Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria.
Wall MK; Mitchenall LA; Maxwell A
Proc Natl Acad Sci U S A; 2004 May; 101(20):7821-6. PubMed ID: 15136745
[TBL] [Abstract][Full Text] [Related]
3. Arabidopsis thaliana GYRB3 does not encode a DNA gyrase subunit.
Evans-Roberts KM; Breuer C; Wall MK; Sugimoto-Shirasu K; Maxwell A
PLoS One; 2010 Mar; 5(3):e9899. PubMed ID: 20360860
[TBL] [Abstract][Full Text] [Related]
4. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
6. Developing ciprofloxacin analogues against plant DNA gyrase: a novel herbicide mode of action.
Wallace MD; Waraich NF; Debowski AW; Corral MG; Maxwell A; Mylne JS; Stubbs KA
Chem Commun (Camb); 2018 Feb; 54(15):1869-1872. PubMed ID: 29388638
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
[TBL] [Abstract][Full Text] [Related]
8. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
Deguchi T; Kikuchi M; Yasuda M; Ito S
J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium.
Kongsoi S; Changkwanyeun R; Yokoyama K; Nakajima C; Changkaew K; Suthienkul O; Suzuki Y
Drug Test Anal; 2016 Oct; 8(10):1065-1070. PubMed ID: 26514939
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
Strahilevitz J; Hooper DC
Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
[TBL] [Abstract][Full Text] [Related]
11. Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
Yague G; Morris JE; Pan XS; Gould KA; Fisher LM
Antimicrob Agents Chemother; 2002 Feb; 46(2):413-9. PubMed ID: 11796351
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.
Tran JH; Jacoby GA; Hooper DC
Antimicrob Agents Chemother; 2005 Jan; 49(1):118-25. PubMed ID: 15616284
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Campylobacter jejuni DNA gyrase as the target of quinolones.
Changkwanyeun R; Usui M; Kongsoi S; Yokoyama K; Kim H; Suthienkul O; Changkaew K; Nakajima C; Tamura Y; Suzuki Y
J Infect Chemother; 2015 Aug; 21(8):604-9. PubMed ID: 26096494
[TBL] [Abstract][Full Text] [Related]
15. The small subunit 1 of the Arabidopsis isopropylmalate isomerase is required for normal growth and development and the early stages of glucosinolate formation.
Imhof J; Huber F; Reichelt M; Gershenzon J; Wiegreffe C; Lächler K; Binder S
PLoS One; 2014; 9(3):e91071. PubMed ID: 24608865
[TBL] [Abstract][Full Text] [Related]
16. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics Simulations of Quinolone Resistance-Associated T86I and P104S Mutations in Campylobacter jejuni gyrA: Unraveling Structural Repercussions.
Mehla K; Ramana J
Microb Drug Resist; 2018 Apr; 24(3):232-243. PubMed ID: 28759328
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of plasmid-mediated quinolone resistance.
Tran JH; Jacoby GA
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5638-42. PubMed ID: 11943863
[TBL] [Abstract][Full Text] [Related]
19. WQ-3810 exerts high inhibitory effect on quinolone-resistant DNA gyrase of
Koide K; Kongsoi S; Nakajima C; Suzuki Y
Biosci Biotechnol Biochem; 2019 Dec; 83(12):2249-2256. PubMed ID: 31382821
[TBL] [Abstract][Full Text] [Related]
20. Travelers' Diarrhea-Associated Enterotoxigenic Escherichia coli gyrA Mutants and Quinolone Antibiotic Affinity: A Molecular Dynamics Simulation and Residue Interaction Network Analysis.
Mehla K; Ramana J
OMICS; 2016 Nov; 20(11):635-644. PubMed ID: 27753544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
